EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Effects of Selected Anionic β -Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats

Keiko Uehata, Takayuki Anno, Kayoko Hayashida, Keiichi Motoyama, Taishi Higashi, Fumitoshi Hirayama, Naomi Ono, James D Pipkin, Kaneto Uekama, Hidetoshi Arima

Journal of Drug Delivery · 2011

DOI: 10.1155/2011/195146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drug Delivery, 2011. Verfasst von Keiko Uehata und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Cy Dex Pharmaceuticals Inc.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin glargine is a synthetic long-acting insulin product used for patients with diabetes mellitus. In this study, to obtain the further desirable blood-glucose lowering profile of insulin glargine, we investigated the effects of β -cyclodextrin sulfate (Sul- β -CyD) and sulfobutylether β -cyclodextrin (SBE7- β -CyD) on physicochemical properties of insulin glargine and pharmacokinetics/pharmacodynamics of insulin glargine after subcutaneous injection to rats. Sul- β -CyD and SBE7- β -CyD increased solubility of insulin glargine. SBE7- β -CyD suppressed the formation of oligomer and enhanced the dissolution rate of insulin glargine from its precipitate, compared to that of Sul- β -CyD. Additionally, we revealed that after subcutaneous administration of an insulin glargine solution, SBE7- β -CyD, but not Sul- β -CyD, increased bioavailability and sustained the blood-glucose lowering effect, possibly due to the inhibitory effects of SBE7- β -CyD on the enzymatic degradation at the injection site. These results suggest that SBE7- β -CyD could be a useful excipient for sustained release of insulin glargine.

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Kumamoto University, 5-1 Oe-honmachi, Kumamoto 862-0973, Japan.

Förderung

  • Cy Dex Pharmaceuticals Inc

Zitieren

APA

Uehata, K., Anno, T., Hayashida, K., Motoyama, K., Higashi, T., Hirayama, F., Ono, N., Pipkin, J. D., Uekama, K., & Arima, H. (2011). Effects of Selected Anionic β -Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats. Journal of Drug Delivery. https://doi.org/10.1155/2011/195146

Vancouver

Uehata K, Anno T, Hayashida K, Motoyama K, Higashi T, Hirayama F, et al. Effects of Selected Anionic β -Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats. Journal of Drug Delivery. 2011. doi:10.1155/2011/195146

BibTeX
@article{Uehata2011,
  author = {Uehata, Keiko and Anno, Takayuki and Hayashida, Kayoko and Motoyama, Keiichi and Higashi, Taishi and Hirayama, Fumitoshi and Ono, Naomi and Pipkin, James D and Uekama, Kaneto and Arima, Hidetoshi},
  title = {Effects of Selected Anionic β -Cyclodextrins on Persistence of Blood Glucose Lowering by Insulin Glargine after Subcutaneous Injection to Rats},
  journal = {Journal of Drug Delivery},
  year = {2011},
  doi = {10.1155/2011/195146}
}
Kostenlos starten →